Tus%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd

# TUSQ-QD ## Overview TUSQ-QD is a combination medication containing **tuberculosis (TB) treatment drugs**. The exact formulation and strengths of TUSQ-QD can vary. This combination is typically used for the treatment of **active tuberculosis**. It is crucial to confirm the specific components and their concentrations in the TUSQ-QD product being prescribed. ## Primary Indications * Treatment of active tuberculosis. ## Adult Dosing Dosing is highly individualized based on the phase of TB treatment (intensive or continuation), patient weight, TB drug susceptibility testing, and local treatment guidelines. A common adult regimen may involve fixed-dose combinations (FDCs) of isoniazid, rifampicin, pyrazinamide, and ethambutol. The specific daily dose of TUSQ-QD will depend on the strengths of these individual agents within the FDC and the patient's weight. For example, in many standard regimens, the dose of isoniazid is 5 mg/kg/day, rifampicin is 10 mg/kg/day, pyrazinamide is 25 mg/kg/day, and ethambutol is 15-25 mg/kg/day. A single FDC tablet or a specific number of tablets would be prescribed to achieve these target doses. **Always refer to local TB treatment guidelines and the specific product monograph for precise dosing instructions.** ## Pediatric Dosing Pediatric dosing for TB treatment is weight-based and follows specific guidelines. Similar to adults, TUSQ-QD would be dosed to achieve target mg/kg/day for each component. * **Isoniazid:** 5-10 mg/kg/day (maximum 300 mg/day) * **Rifampicin:** 10-20 mg/kg/day (maximum 600 mg/day) * **Pyrazinamide:** 20-35 mg/kg/day (maximum 2 g/day) * **Ethambutol:** 15-25 mg/kg/day (maximum 1.6 g/day) **Exact pediatric dosing must be determined by a healthcare professional experienced in pediatric TB management, adhering to current guidelines.** ## Dose Adjustments * **Renal Impairment:** Dose adjustments may be necessary for components like isoniazid and ethambutol. Consult renal dosing guidelines. * **Hepatic Impairment:** Most components of TB treatment carry a risk of hepatotoxicity. Use with caution and consider dose reduction or discontinuation if hepatic function declines significantly. * **Weight-Based Dosing:** Doses are typically adjusted based on patient weight. ## Contraindications * Known hypersensitivity to any component of TUSQ-QD. * Severe hepatic disease (especially with pyrazinamide and isoniazid). * Severe renal impairment may require dose adjustment for certain components. * Optic neuritis (caution with ethambutol). ## Adverse Effects * **Hepatotoxicity:** Common with isoniazid, rifampicin, and pyrazinamide. Monitor liver function tests. * **Gastrointestinal Upset:** Nausea, vomiting, abdominal pain. * **Peripheral Neuropathy:** More common with isoniazid, can be mitigated with pyridoxine (Vitamin B6). * **Ocular Toxicity:** Blurred vision, visual field defects (ethambutol). * **Hematologic Effects:** Thrombocytopenia, hemolytic anemia (rifampicin). * **Skin Reactions:** Rash, pruritus. * **Arthralgia/Gout:** Can be precipitated by pyrazinamide. ## Key Drug Interactions * **CYP450 Interactions:** Rifampicin is a potent inducer of CYP enzymes, affecting the metabolism of many drugs (e.g., warfarin, oral contraceptives, antiretrovirals, antifungals). * **Antacids:** May decrease absorption of rifampicin. * **Other Hepatotoxic Agents:** Concurrent use increases the risk of liver injury. * **Pyridoxine:** Often co-administered with isoniazid to prevent peripheral neuropathy. ## Monitoring * **Liver Function Tests (LFTs):** Baseline and periodic monitoring. * **Renal Function Tests:** Baseline and periodic monitoring, especially if dose adjustments are made. * **Vision Assessment:** Baseline and periodic checks if using ethambutol. * **Complete Blood Count (CBC):** Baseline and periodically, especially if hematologic effects are suspected. * **Sputum Smear and Culture:** To assess treatment response. * **Adherence:** Crucial for treatment success. ## Clinical Pearls * TUSQ-QD is typically part of a multi-drug regimen for TB. * **Adherence is paramount.** Missed doses or incomplete treatment can lead to drug resistance. * Pyridoxine (Vitamin B6) supplementation is often recommended with isoniazid therapy to prevent peripheral neuropathy. * Rifampicin can stain body fluids (urine, sweat, tears) orange-red. * All components can cause hepatotoxicity; patients should be educated to report symptoms like jaundice, dark urine, or abdominal pain. *** **Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information, local guidelines, and conduct a thorough patient assessment before making any clinical decisions. Drug formulations and recommendations can change.